Patients with inflammatory bowel disease (IBD) and bowel resection might experience reduced effectiveness from oral contraceptive agents. We report a case of a woman with Crohn disease who became pregnant while compliant with her combined oral contraceptive pill (OCP) regimen. Patients with Crohn disease have a greater risk of contraceptive failure because the diseased bowel causes increased pa...

Oral contraceptives remain a popular method of contraception over 50 years after their introduction. While safe and effective for many women, the failure rate of oral contraception is about 8%. Concerns about the risk of venous thromboembolism continue to drive the search for the safest oral contraceptive formulations. The oral contraceptive NOMAC-E2 contains nomegestrol acetate (NOMAC) 2.5 mg ...

This report looks at data from 17 032 women who took part in the Oxford Family Planning Association contraceptive study. Thirty-eight first accidental pregnancies occurred during 6779 woman-years of use of progestogen-only oral contraceptives (0.56 per 100) and 95 first accidental pregnancies occurred during 48 692 woman-years of combined oral contraceptive use (0.20 per 100). Although associat...

Drovelis is a new combined oral contraceptive (COC) containing drospirenone and estetrol. This article discusses its dosing requirements, clinical trial efficacy adverse effects.

Background: Among the non-surgical methods of preventing conception, taking oral contraceptive pills is the most common way. Some of the studies have shown that contraceptive pills due to containing estrogen and progesterone cause lipid peroxidation and as a consequence increase the level of oxidative stress. Aim: To compare the level of plasma Malone dialdehide in LD contraceptive pill and con...

Oral contraceptives are a safe and effective form of birth control used by millions of women in the United States and around the world. There have been anecdotal reports of unintended pregnancies after antibiotics were prescribed to women on oral contraceptives. Dentists and physicians have therefore been advised to warn female patients on oral contraceptives of a potential interaction and to a...

Contraceptive use among women Veterans may not be adequately captured using administrative and pharmacy codes. Clinical progress notes may provide a useful alternative. The objectives of this study were to validate the use of administrative and pharmacy codes to identify contraceptive use in Veterans Health Administration data, and to determine the feasibility and validity of identifying contra...

This new transdermal contraceptive system (contraceptive patch), Evra (Janssen-Cilag), received a UK product licence in 2003. In clinical trials: Consistent doses of norelgestromin and ethinyl oestradiol are released into the systemic circulation daily. Pharmacokinetic data suggest that levels are sufficient to inhibit ovulation for at least 7 days. The overall Pearl index for the contraceptive...

AIM This study assessed the influence of current oral contraceptive pills on periodontal health in young females. METHODS AND MATERIALS Seventy women ranging in age from 17 to 35 years (mean 24 years) had a comprehensive periodontal examination. Their current and previous oral contraceptive pill use was assessed by a questionnaire. A periodontal assessment was performed that included recordin...